Total Payments
$28,335
2024 Payments
$1,046
Companies
23
Transactions
224
Medicare Patients
5,555
Medicare Billing
$648,906
Payment Breakdown by Category
Other$23,415 (82.6%)
Food & Beverage$4,121 (14.5%)
Education$460.73 (1.6%)
Travel$338.13 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,415 | 10 | 82.6% |
| Food and Beverage | $4,121 | 191 | 14.5% |
| Education | $460.73 | 21 | 1.6% |
| Travel and Lodging | $338.13 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $24,829 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $985.55 | 45 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $497.61 | 25 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $338.04 | 18 | $0 (2024) |
| Amgen Inc. | $216.99 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $202.73 | 5 | $0 (2024) |
| Vifor Pharma, Inc. | $158.52 | 7 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $144.17 | 7 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $131.40 | 7 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $125.44 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,046 | 50 | Bayer Healthcare Pharmaceuticals Inc. ($201.21) |
| 2023 | $8,670 | 73 | Bayer Healthcare Pharmaceuticals Inc. ($7,494) |
| 2022 | $18,112 | 77 | Bayer HealthCare Pharmaceuticals Inc. ($17,034) |
| 2021 | $337.31 | 18 | Bayer HealthCare Pharmaceuticals Inc. ($99.45) |
| 2019 | $34.16 | 2 | Shire North American Group Inc ($21.44) |
| 2018 | $22.38 | 2 | PFIZER INC. ($11.53) |
| 2017 | $113.04 | 2 | Novartis Pharmaceuticals Corporation ($99.96) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: NEPHROLOGY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Nephrology | ||||||
| 10/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $25.88 | General |
| Category: NEPHROLOGY | ||||||
| 10/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/03/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 08/27/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Cardio-renal | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.88 | General |
| 08/01/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $3.52 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,056 | 3,203 | $783,233 | $225,019 |
| 2022 | 18 | 2,342 | 4,164 | $923,734 | $287,771 |
| 2021 | 15 | 1,157 | 1,794 | $427,730 | $136,116 |
Total Patients
5,555
Total Services
9,161
Medicare Billing
$648,906
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 100 | 369 | $376,380 | $94,286 | 25.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 203 | $30,653 | $17,845 | 58.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 280 | $42,560 | $16,439 | 38.6% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 22 | 74 | $63,936 | $15,502 | 24.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 110 | 110 | $35,530 | $15,455 | 43.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 109 | 251 | $26,606 | $14,619 | 54.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 93 | 103 | $30,900 | $12,873 | 41.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 29 | 48 | $41,328 | $10,199 | 24.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 79 | 149 | $39,634 | $7,708 | 19.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 80 | $17,840 | $7,439 | 41.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 218 | 280 | $31,360 | $2,861 | 9.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 28 | $6,020 | $2,560 | 42.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 223 | 303 | $3,030 | $2,531 | 83.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 219 | 278 | $21,962 | $2,090 | 9.5% |
| 84100 | Phosphate level | Office | 2023 | 219 | 281 | $6,182 | $1,292 | 20.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 254 | 348 | $7,656 | $1,175 | 15.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 14 | 18 | $1,656 | $144.32 | 8.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 89 | 335 | $341,700 | $91,004 | 26.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 166 | 435 | $65,685 | $32,638 | 49.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 186 | 220 | $66,000 | $31,679 | 48.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 184 | 446 | $47,276 | $23,728 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 262 | $39,824 | $22,241 | 55.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 59 | 97 | $83,517 | $21,869 | 26.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 139 | 311 | $82,726 | $17,136 | 20.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 25 | 73 | $63,072 | $15,710 | 24.9% |
About Dr. Thomas Bell, D.O
Dr. Thomas Bell, D.O is a Internal Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1801248810.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Bell, D.O has received a total of $28,335 in payments from pharmaceutical and medical device companies, with $1,046 received in 2024. These payments were reported across 224 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,415).
As a Medicare-enrolled provider, Bell has provided services to 5,555 Medicare beneficiaries, totaling 9,161 services with total Medicare billing of $648,906. Data is available for 3 years (2021–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Greensboro, NC
- Active Since 07/01/2016
- Last Updated 08/11/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801248810
Products in Payments
- Kerendia (Drug) $24,829
- FARXIGA (Drug) $702.42
- JYNARQUE (Drug) $497.61
- RAYALDEE (Drug) $338.04
- LOKELMA (Drug) $183.14
- LUPKYNIS (Drug) $144.17
- ACTHAR (Biological) $131.40
- Velphoro (Drug) $125.44
- BENLYSTA (Biological) $122.16
- JARDIANCE (Drug) $115.52
- BRILINTA (Drug) $99.99
- ENTRESTO (Drug) $99.96
- INJECTAFER (Drug) $88.56
- TAVNEOS (Drug) $70.65
- KRYSTEXXA (Biological) $67.31
- Auryxia (Drug) $64.97
- PURIFIED CORTROPHIN GEL (Drug) $60.74
- Veltassa (Drug) $58.93
- Aranesp (Biological) $54.94
- Korsuva (Drug) $45.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greensboro
Dr. Daniel Bensimhon, Md, MD
Internal Medicine — Payments: $2.3M
Internal Medicine $2.3M
Dr. Michael Wert, M.d, M.D
Internal Medicine — Payments: $439,242
Internal Medicine $439,242
Mark Russo, Md, MD
Internal Medicine — Payments: $318,372
Internal Medicine $318,372
Julian Hutchins, Md, MD
Internal Medicine — Payments: $222,266
Internal Medicine $222,266
Dr. James Beekman, Md, MD
Internal Medicine — Payments: $116,445
Internal Medicine $116,445
Walter Pharr, M.d, M.D
Internal Medicine — Payments: $53,823
Internal Medicine $53,823